HOME > COLUMN

COLUMN

Maurer's Healthcare Insight (115)

November 16, 2009
Maurer's Healthcare Insight (114)

October 26, 2009
Maurer's Healthcare Insight (113)

October 5, 2009
Maurer's Healthcare Insight (112)

September 14, 2009
Maurer's Healthcare Insight (111)

August 24, 2009
Maurer's Healthcare Insight (110)

July 27, 2009
Maurer's Healthcare Insight (109)

June 22, 2009
Maurer's Healthcare Insight (108)

May 18, 2009
Maurer's Healthcare Insight (107)

April 27, 2009
Maurer's Healthcare Insight (106)

March 30, 2009
Maurer's Healthcare Insight (105)

March 2, 2009
Maurer's Healthcare Insight (104)

January 26, 2009
Maurer's Healthcare Insight (103)

January 5, 2009
Maurer's Healthcare Insight (102)

December 8, 2008
Maurer's Healthcare Insight (101)

December 1, 2008
Maurer's Healthcare Insight (100)

October 27, 2008
Maurer's Healthcare Insight (99)

September 29, 2008
Maurer's Healthcare Insight (98)

August 25, 2008
Maurer's Healthcare Insight (97)

July 28, 2008
Maurer's Healthcare Insight (96)

June 23, 2008

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…